Wed, Nov 02, 2022
Sun Pharma share price: Post second quarter results, brokerages have revised the target price on the stock
More >
Wed, Feb 14, 2018
The company posted consolidated profit after tax (PAT) of Rs 365.39 crore - declining by 75.17% compared to Rs 1,471.82 crore in the corresponding period of the previous year.
Tue, Nov 14, 2017
Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said.
Mon, May 29, 2017
Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
